Proteomics company raises $128 Million in Series C financing
Proteomics company Alamar Biosciences closed $100 million in Series C financing with the second close of an additional $28 million expected to happen within the next 30 days. This new capital brings Alamar’s total funding to date to nearly $250 million. The financing round was led… Read More